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Apolipoprotein E knockout miceTriacylglycerols (TG) are the major storage molecules of metabolic energy and fatty acids in several tissues.
The ﬁnal step in TG biosynthesis is catalyzed by acyl-CoA:diacylglycerol acyltransferase (DGAT) enzymes.
Lack of whole body DGAT1 is associated with reduced lipid-induced inﬂammation. Since one major compo-
nent of atherosclerosis is chronic inﬂammation we hypothesized that DGAT1 deﬁciency might ameliorate
atherosclerotic lesion development. We therefore crossbred Apolipoprotein E-deﬁcient (ApoE−/−) mice
with Dgat1−/− mice. ApoE−/− and ApoE−/−Dgat1−/− mice were fed Western-type diet (WTD) for 9 weeks
and thereafter examined for plaque formation. The mean atherosclerotic lesion area was substantially re-
duced in ApoE−/−Dgat1−/− compared with ApoE−/−mice in en face and aortic valve section analyses. The re-
duced lesion size was associated with decreased cholesterol uptake and absorption by the intestine, reduced
plasma TG and cholesterol concentrations and increased cholesterol efﬂux from macrophages. The expres-
sion of adhesion molecules was reduced in aortas of ApoE−/−Dgat1−/− mice, which might be the reason
for less migration capacities of monocytes and macrophages and the observed decreased amount of macro-
phages within the plaques. From our results we conclude that the lack of DGAT1 is atheroprotective, impli-
cating an additional application of DGAT1 inhibitors with regard to maintaining cholesterol homeostasis
and attenuating atherosclerosis.oA:diacylglycerol acyltransfer-
terol; TC, total cholesterol; TG,
ratky).
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In mammalian cells, neutral lipids including cholesteryl esters and
triacylglycerols (TG) form lipid droplets as storage organelles. TG are
the major storage molecules of metabolic energy and fatty acids (FAs)
in most cells and tissues. The ﬁnal step in TG biosynthesis is catalyzed
by acyl-CoA:diacylglycerol acyltransferase (DGAT) enzymes. In mice,
DGAT1 is expressed ubiquitously with highest mRNA levels in the
small intestine, testis, adipose tissue, and mammary gland [1].
DGAT2 is expressed in adipose tissue, liver and many other tissues,
including cardiac muscle, small intestine, skeletal muscle, and kidney
[2]. DGAT2 is speculated to be closely linked to endogenous FAbiosynthesis and esteriﬁcation, whereas DGAT1 might be involved
in the recycling of hydrolyzed TG by reesterifying the FAs [3].
DGAT2 deﬁciency in mice causes early postnatal lethality and a severe
decrease in carcass TG content [4]. Dgat1-deﬁcient (Dgat1−/−) mice
are lean, resistant to diet-induced obesity and show substantially de-
creased DGAT activity in several tissues [5]. Reduced body weight in
Dgat1−/− mice correlates with an increased rate of energy expendi-
ture and a delayed transit of TG through the enterocyte into the circu-
lation [6]. Whole-body DGAT1 deﬁciency was associated with
reduced inﬂammation in adipose tissue, whereas DGAT1 deﬁciency
in isolated macrophages increased the propensity of FA-induced in-
ﬂammation [7]. It has recently been shown that obesity resistance
of Dgat1−/−mice was due to the absence of intestinal DGAT1 expres-
sion [8]. aP2-Dgat1 transgenic mice with increased DGAT1 levels in
adipocytes and macrophages were prone to diet-induced obesity
but were protected against non-adipose tissue steatosis and systemic
inﬂammation [7].
Since atherosclerosis is an inﬂammatory disease our study was
designed to investigate the consequences of whole-body DGAT1 deﬁ-
ciency on atherosclerosis susceptibility. Atherosclerosis is character-
ized by lipid accumulation and an inﬂammatory response in the
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tion attract monocytes, which adhere to the endothelium with the
help of certain adhesion molecules. Monocytes enter the intima
through the endothelium and acquire morphological characteristics
of macrophages by increasing the expression of scavenger receptor
A (SRA) and cluster of differentiation 36 (CD36). As a consequence,
macrophages internalize modiﬁed lipoproteins and accumulate cho-
lesteryl esters that ultimately lead to foam cell formation, a character-
istic of early atherosclerotic lesions. To study the involvement of
DGAT1 in atherogenesis, Dgat1−/− mice [5] were cross-bred with
Apolipoprotein E (ApoE)−/− mice, an atherosclerosis-susceptible
strain with impaired clearance of ApoB-containing lipoproteins
[11,12]. We observed substantially reduced plaque formation in
ApoE−/−Dgat1−/− mice compared with ApoE−/− mice. Our results
suggest that the protection against atherosclerosis is multifactorial,
including reduced aortic inﬂammation and adaptive changes in intes-
tinal and macrophage cholesterol metabolism.
2. Theory
Dgat1−/−mice are resistant to diet-induced obesity and fatty liver
disease, exhibit increased energy expenditure, preserve insulin and
leptin sensitivity, and are resistant to FA-induced inﬂammation.
DGAT1 inhibitors were shown to induce weight loss and improve in-
sulin sensitivity, glucose tolerance and lipid levels in obese mice, sug-
gesting that these compounds may be beneﬁcial in the treatment of
obesity, diabetes and dyslipidemia. Since DGAT1 deﬁciency is linked
with phenotypic components that are generally associated with re-
duced atherosclerosis susceptibility we hypothesized that DGAT1 de-
ﬁciency attenuates atherosclerotic plaque formation in ApoE−/−mice.
3. Materials and methods
3.1. Animals
Dgat1−/− [5] andApoE−/−mice (The Jackson Laboratory, BarHarbor,
ME, USA) were crossed to yield ApoE−/−Dgat1−/− mice. All mice were
housed in sterilized ﬁlter-top cages and given unlimited access to food
and water. The mice were maintained on regular chow diet, contain-
ing 4.3% (w/w) fat with no added cholesterol (Ssniff, Soest, Germany)
on a regular 12 h dark/light cycle. At the age of 6–8 weeks, female
ApoE−/−and ApoE−/−Dgat1−/−mice were challenged with a Western-
type diet (WTD; 21% fat, 0.4% cholesterol; Ssniff) for 9 weeks to induce
atherosclerotic lesion development. All experimental protocols were
approved by the Austrian Federal Ministry of Science and Research,
Division of Genetic Engineering and Animal Experiments (Vienna,
Austria).
3.2. Lipid analyses in plasma and small intestines
Blood was collected by retro-orbital venous plexus puncture after
an overnight fasting period. TG, free cholesterol (FC) (both from
DiaSys, Holzheim, Germany) and total cholesterol (TC) (Greiner Diag-
nostics AG, Bahlingen, Germany) concentrations were determined
spectrophotometrically. Free fatty acid (FFA) concentrations were
assayed using a NEFA FS kit (DiaSys, Holzheim, Germany) according
to the manufacturer's protocol. Bile acid concentrations in the plasma
were determined in the fed state in ApoE−/− and ApoE−/−Dgat1−/−
mice fed with WTD for 9 weeks (DiaSys, Holzheim, Germany). To
analyze lipid parameters in the small intestine, ApoE−/− and
ApoE−/−Dgat1−/−mice were fed with WTD for 4 weeks. After a fast-
ing period of 4 h themiddle part of the small intestine (jejunum)was
collected. The lipids were extracted by the addition of 2 ml hexane:
isopropanol (3:2, v:v) for 1 h at 4 °C. The lipid extract was dried
under a stream of nitrogen. One hundred microliters 1% Triton-
X100 in chloroform was added and dried again under nitrogen.Thereafter, the samples were dissolved in 100 μl dH2O, and TG and
TC concentrations were measured using above mentioned kits. The
readings were normalized to protein concentrations.
3.3. Lipoprotein proﬁles
ApoE−/− and ApoE−/−Dgat1−/− mice were fed chow diet. Mice
were fasted for 4 h and plasma was isolated. A pool of 200 μl per ge-
notype was subjected to fast protein liquid chromatography (FPLC)
on a Pharmacia FPLC system (Pﬁzer Pharma, Karlsruhe, Germany)
equipped with a Superose 6 column (Amersham Biosciences, Piscat-
away, NJ). The lipoproteins were eluted with 10 mM Tris–HCl, 1 mM
EDTA, 0.9% NaCl, and 0.02% NaN3 (pH 7.4). Fractions of 0.5 ml each
were collected and TG and TC concentrations were assayed enzymat-
ically using above mentioned kits. To enhance sensitivity, reaction
buffers were supplemented by the addition of sodium 3,5-dichloro-
2-hydroxy-benzenesulfonate.
3.4. Preparation of histological sections and lesion analysis
Atherosclerotic lesions in aortic root and aorta of ApoE−/− and
ApoE−/−Dgat1−/− mice were analyzed after 9 weeks feeding the
WTD. Mice were euthanized and then the arterial tree was perfused
in situ with PBS (100 mm Hg) for 10 min via a cannula in the left ven-
tricular apex. Liver and small intestine were collected and mice were
perfused with 4% neutral-buffered formalin (Carl Roth GmbH, Vienna,
Austria) for 15 min. After ﬁxing hearts, livers and intestines in 4%
neutral-buffered formalin, serial sections (8 μm) were cut (HM 560
Cryo-Star; Microm International GmbH, Walldorf, Germany). Images
of the atherosclerotic lesion areas in oil red-O (Sigma-Aldrich, St.
Louis, MO) stained sections were taken with ScanScope T3 whole
slide scanner (Aperio Technologies, Bristol, UK). Plaque areas were
quantitated by ImageJ software and a software algorithm which had
been programmed with Interactive Data Language (IDL, ITT Visual In-
formation Solutions, Boulder, USA) [13]. Mean lesion area was calcu-
lated from 10 consecutive oil red O-stained sections, starting at the
appearance of the tricuspid valves. Sections were stained immunohis-
tochemically for the presence of macrophages using a monoclonal
rat anti-mouse Moma-2 antibody (1:600) (Acris, Hiddenhausen,
Germany).
For en face analysis, aortas were dissected and plaques were
stained with oil red O as described recently [13]. Images were ana-
lyzed using ImageJ software. Images of oil red O-stained liver and in-
testine sections were taken with a Nikon Eclipse 80i microscope
(Nikon, Vienna, Austria).
3.5. Cell culture
Macrophages were isolated from the peritoneum of ApoE−/− and
ApoE−/−Dgat−/− mice 3 days after intraperitoneal injection of 3 ml
3% thioglycolate medium. Cells were washed three times with PBS
and cultivated in Dulbecco's modiﬁed Eagle's medium (DMEM), 10%
lipoprotein-deﬁcient serum (LPDS), 100 μg/ml penicillin/streptomycin
in the absence and presence of 100 μg/ml acetylated (ac)LDL for
24 h. LDL and HDL were isolated from human plasma by density gra-
dient ultracentrifugation and LDL was acetylated as described [14].
Protein was quantitated using a Bradford assay (Bio-Rad Laboratories,
Hercules, CA).
3.6. DiI-acLDL and DiI-VLDL uptake
Macrophages were cultured in DMEM/10% LPDS in 12-well culture
plates for 24 h. Thereafter, cells were incubated in serum-free DMEM
with 10 μg/ml 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine
perchlorate (DiI)-acLDL and 50 μg/ml DiI-VLDL for 4 h. Cells were
washed thrice with PBS, detached by scraping, stained with F4/80
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analyzed by ﬂuorescence activated cell sorting (FACS) (FACSCalibur;
BD Biosciences, San Jose, CA).
3.7. Cellular cholesterol efﬂux
Macrophages were incubated with 100 μg 0.5 μCi/ml 3H-cholesterol
(ARC Inc., St. Louis, MO) and 30 μg/ml non-labeled cholesterol in
DMEM/0.2% FA-free BSA for 32 h at 37 °C. After washing the cells
twice with PBS, the cells were incubated for 16 h in equilibrationmedi-
um (DMEM/0.2% FA-free BSA in the absence or presence of 0.3 mM
8-bromo-cAMP (Sigma-Aldrich, St. Louis,MO)).We determined choles-
terol efﬂux after incubating the cells in DMEM/0.2% FA-free BSA in the
absence or presence of 15 μg/ml ApoA-I (Calbiochem, La Jolla, CA) or
100 μg/ml HDL3. Radioactivity in 100 μl medium and in the cells was
measured by scintillation counting after 1, 3, 6, and 9 h of incubation.
Cholesterol efﬂux is expressed as the percentage of total cell 3H-
cholesterol present in the medium after 1, 3, 6, and 9 h. Basal efﬂux
in the absence of ApoA-I and HDL3was subtracted from the data shown.
3.8. Migration assay
We assessed cell migration using ~2 million peritoneal macro-
phages or bone marrow monocytes loaded into the upper wells of
24-well transwell plates (macrophages: 5 μm pore size; monocytes:
3 μm pore size; Corning, Lowell, MA). The lower chambers were ﬁlled
with 600 μl DMEM containing monocyte chemoattractant protein 1
(MCP-1, 50 ng/ml). The amount of monocytes and macrophages in
the lower chambers were determined after 4 h at 37 °C by FACS
(FACSCalibur; BD Biosciences, San Jose, CA). The chemotactic index
was calculated as the ratio of cells that had moved from the top to
the lower chamber in the presence or absence of MCP-1.
3.9. Nile red staining and ﬂuorescence microscopy
We plated macrophages from chow or WTD-fed ApoE−/− and
ApoE−/−Dgat1−/− mice on chamber slides in serum-free DMEM for
24 h, ﬁxed them with paraformaldehyde and stained the lipid drop-
lets with Nile red [15]. Lipid droplets were visualized by confocal
laser scanning microscopy as described previously [15] using an
LSM 510 META microscope system (Carl Zeiss GmbH, Vienna,
Austria).
3.10. mRNA expression analysis by real time PCR
Total RNA from aortas and intestines was isolated using TriFast
(Peqlab, Erlangen, Germany). Total RNA from macrophages was iso-
lated using peqGOLD kit (Peqlab, Erlangen, Germany). RNA was re-
verse transcribed using the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Foster City, CA). Quantitative
real time PCR was performed on a LightCycler 480 system (Roche,
Basel, Switzerland) using the Quantifast SYBR Green PCR kit (Qiagen,
Hilden, Germany). Data are displayed as expression ratios of target
genes normalized to the expression of cyclophilin A as internal refer-
ence in each sample. Data were analyzed using the 2-ddCt method.
Primer sequences are available upon request.
3.11. Western blotting
Macrophages from ApoE−/− and ApoE−/−Dgat1−/−mice were cul-
tured in DMEM/10% LPDS and incubated with acLDL (100 μg/ml) for
24 h. Macrophages were lysed and 40 μg of protein lysates were sep-
arated by 15% SDS-PAGE. After transfer onto nitrocellulose protran
BA85 membranes (Whatman, Vienna, Austria), membranes were
blocked with 5% BSA for 2 h and incubated with rabbit polyclonal an-
tibodies to murine ABCA1 (1:1000), ABCG1 (1:500), SRB-1 (1:1000)(Acris, Hiddenhausen, Germany), and a monoclonal anti-mouse
β-actin (1:5000) (Santa Cruz Biotechnology, Heidelberg, Germany).
The horseradish peroxidase-conjugated goat anti-rabbit (1:5000)
(Santa Cruz Biotechnology) and rabbit anti-mouse antibodies (Dako,
Glostrup, Denmark) were visualized by enhanced chemilumines-
cence detection (ECL Plus, GE Healthcare, Piscataway, NJ) on an
AGFA Curix Ultra X-ray ﬁlm.3.12. MCP-1 ELISA
Blood was drawn from WTD-fed ApoE−/− and ApoE−/−Dgat1−/−
mice. Serum MCP-1 concentrations were determined by ELISA (R&D
Systems Inc., Minneapolis, MN) according to the manufacturer's
protocol.3.13. DGAT activity
DGAT activity was determined as described by Buhman et al. [6]
with minor modiﬁcations. Brieﬂy, TG formation in 50 μg macrophage
lysates was measured using 200 μM sn-1,2-dioleoylglycerol (Sigma-
Aldrich, St. Louis, MO) and 25 μM 14C-oleoyl-CoA (ARC Inc., St.
Louis, MO) as substrates and 10 mMMgCl2. After 5 min of incubation
at 37 °C, lipids were extracted with chloroform:methanol (2:1, v:v).
The organic layer was dried under nitrogen and redissolved in
human serum and chloroform:methanol (1:1, v:v). Lipids were sepa-
rated by thin layer chromatography in hexane:diethyl ether:acetic
acid (79:20:1). TG-speciﬁc bands were scraped and the radioactivity
was measured by liquid scintillation counting.3.14. Cholesterol absorption and cholesterol synthesis
We determined acute cholesterol uptake and absorption in over-
night fasted ApoE−/− and ApoE−/−Dgat1−/−mice. Mice were gavaged
with 200 μl corn oil containing 2 μCi 1,2-3H(N)-cholesterol (ARC Inc.,
St Louis, MO) and 0.2 mg cholesterol. After 4 h, plasma, liver and
small intestine were isolated. The small intestine was rinsed with
PBS to remove luminal contents. The tissues were dissolved in 1 M
NaOH at 65 °C overnight and then analyzed by liquid scintillation
counting. We determined the amount of 3H-cholesterol in HDL after
precipitation of ApoB-containing lipoproteins with Quantolip HDL
(Technoclone GmbH, Vienna, Austria). Plasma samples from each ge-
notype were pooled, 200 μl were subjected to FPLC and the radioac-
tivity in 0.5 ml fractions was determined by liquid scintillation
counting. Cholesterol synthesis in ApoE−/− and ApoE−/−Dgat1−/−
mice after injecting 200 μl PBS containing 5 μCi 14 C-acetate (ARC
Inc., St Louis, MO) was assessed as described [16].
Dual fecal sterol loss was determined as described previously [17]
with minor modiﬁcations. Brieﬂy, mice were gavaged with 0.1 μCi
14C-cholesterol and 0.2 μCi 3H-sitosterol (ARC Inc., St Louis, MO) in
200 μl corn oil, and feces were collected for 48 h. Lipids were
extracted from feces using the Folch extraction method and radioac-
tivity was determined by liquid scintillation counting. Fractional cho-
lesterol absorption was calculated by the following formula: dose
[14C]:[3H]− fecal [14C]:[3H])/dose [14C]:[3H].3.15. Statistics
Statistical analyses were performed with GraphPad Prism 5.0 soft-
ware. The signiﬁcance of paired data was determined by Student's t-
test. Data with more than 2 groups or 2 independent variables were
analyzed by ANOVA followed by the Bonferroni post-hoc test. Data
are presented as mean values±SEM. The probability level for statisti-
cal signiﬁcance was set at pb0.05 (*), p≤0.01 (**) and p≤0.001 (***).
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4.1. Reduced plasma lipid concentrations in ApoE−/−Dgat1−/− mice
First, we determined plasma lipid parameters of 6–8 week old fe-
male ApoE−/− and ApoE−/−Dgat1−/− mice fed chow diet. We found
signiﬁcantly reduced concentrations of TG (30%), FFA (27%) and FC
(17%) in ApoE−/−Dgat1−/− compared with ApoE−/− mice, whereas
total cholesterol (TC) and cholesteryl ester (CE) concentrations
remained unchanged (Table 1). To investigate the effect of DGAT1 de-
ﬁciency on early atherosclerosis, ApoE−/− and ApoE−/−Dgat1−/−
mice were fed WTD for 9 weeks. Animals from both genotypes exhib-
ited similar body weights before (14–15 g) and after feeding theWTD
(20–21 g) (supplemental Fig. S1). Plasma TG and FFA concentrations
were signiﬁcantly decreased in WTD-fed ApoE−/−Dgat1−/− com-
pared with ApoE−/− mice (Table 1). In addition, WTD feeding
resulted in a 20% reduction in plasma TC levels and a concomitant
26% decrease in FC concentrations (Table 1). Plasma CE concentra-
tions remained unchanged in ApoE−/−Dgat1−/− compared with
ApoE−/− mice, suggesting that the particle types are unaltered.
4.2. Reduced plaque formation in ApoE−/−Dgat1−/− mice
To study the impact of DGAT1 deﬁciency on atherosclerosis sus-
ceptibility of ApoE−/− mice, we compared plaque formation in
ApoE−/−Dgat1−/− and ApoE−/− mice. Quantiﬁcation of oil red O-
stained en face preparations of aortas revealed a 36% reduction in pla-
que area of ApoE−/−Dgat1−/− compared with ApoE−/−mice (Fig. 1A).
In addition, we observed a 24% decrease of the lesion area in aortic
valve sections of ApoE−/−Dgat1−/− mice (Fig. 1B). Immunohisto-
chemical staining of macrophages in aortic valve sections using the
macrophage-speciﬁc anti-Moma2 antibody demonstrated that the
macrophage area in sections of ApoE−/−Dgat1−/− plaques was 27%
reduced compared with ApoE−/− mice (Fig. 1C).
4.3. ReducedmRNA expression of genes involved inmonocyte recruitment
and decreased migration of ApoE−/−Dgat1−/− macrophages
To investigate whether the reduction in atherosclerosis observed
in ApoE−/−Dgat1−/− mice might directly affect the arterial wall and
to elucidate whether primary rather than secondary effects are in-
volved, we isolated the descending aortas and macrophages from
chow diet-fed mice. First we determined mRNA levels of several
genes known to be responsible for monocyte recruitment and adhe-
sion. We found unchanged mRNA expression of Icam1 but markedly
reduced mRNA levels of Vcam1, P-selectin, E-selectin, and Mcp1 in
aortas of ApoE−/−Dgat1−/− compared with ApoE−/− mice (42%,
35%, 52%, and 38%, respectively) (Fig. 2A). In addition, Vla-4 mRNA
levels were 69% reduced in ApoE−/−Dgat1−/− compared with
ApoE−/− peritoneal macrophages (Fig. 2B). These observations indi-
cate that the lack of DGAT1 might reduce leukocyte inﬁltration by
regulating cell adhesion and transendothelial cell migration. In accor-
dance, by using MCP1 as a chemoattractant, we found markedlyTable 1
Lipid parameters of age-matched female ApoE−/− and ApoE−/−/Dgat−/− mice before and a
were determined enzymatically and CE concentrations were calculated as CE=TC−FC. Da
Genotype n TG (mg/dl) FFA (mM)
Before WTD
ApoE−/− 9 110±13 1.47±0.1
ApoE−/−/Dgat−/− 11 76.5±7.5* 1.07±0.1
After WTD
ApoE−/− 9 270±10 1.74±0.0
ApoE−/−/Dgat−/− 11 159±8.8*** 1.18±0.0decreased migration capacities of peritoneal macrophages and bone
marrow-derived ApoE−/−Dgat1−/−monocytes (58% and 68%, respec-
tively) (Fig. 2C). Reducedmonocyte/macrophage migration to the site
of injury is generally associated with a less inﬂammatory phenotype.
Accordingly, MCP-1 protein levels were decreased by 26% in serum of
WTD-fed ApoE−/−Dgat1−/− compared with ApoE−/− mice (Fig. 2D).
These data suggest that DGAT1 deﬁciency exhibits functional changes
that play an important role in the attenuation of the inﬂammatory re-
sponse in atherosclerosis development of ApoE−/−Dgat1−/− mice.
4.4. Increased cholesterol efﬂux from ApoE−/−Dgat1−/− macrophages
To assesswhether reverse cholesterol transport is affected inApoE−/−
Dgat1−/− macrophages in vitro, we loaded macrophages from chow
diet-fed mice with 3H-cholesterol-labeled acLDL and determined cho-
lesterol efﬂux to ApoA1 and HDL3 as extracellular acceptors after 1, 3,
6, and 9 h. Cholesterol efﬂux was drastically increased in ApoE−/−
Dgat1−/− macrophages compared with ApoE−/− cells and this effect
was even more pronounced after cAMP activation (Fig. 3A–D). To elu-
cidate whether DGAT1 deﬁciency affects cholesterol efﬂux also in the
presence of ApoE, we determined cholesterol efﬂux in macrophages
from Dgat1−/− and Wt mice. As shown in the supplemental Fig. S3,
cholesterol efﬂux to ApoA1 was markedly increased in Dgat1−/− com-
pared with Wt mice.
Next we analyzed mRNA levels of genes involved in cholesterol
efﬂux in acLDL-loaded macrophages from ApoE−/− and ApoE−/−
Dgat1−/− macrophages. We found unchanged Acat1 mRNA expres-
sion but increased mRNA levels of Abca1, Abcg1 and Sr-b1 (1.7-,
6.9- and 3.1-fold, respectively) in ApoE−/−Dgat1−/− foam cells
(Fig. 3E). Accordingly, ABCA1 and ABCG1 protein expressions were
increased in acLDL-loaded macrophages from ApoE−/−Dgat1−/−
mice (Fig. 3F). Although no differences were observed in mRNA and
protein expression of Abca1, Abcg1 and Sr-b1 in unloaded macro-
phages the protein expression of ABCG1 and SR-B1 were increased
(supplemental Fig. S4A, B).
4.5. Reduced foam cell formation in ApoE−/−Dgat1−/− macrophages
To further investigate the role of macrophages in the reduced
atherosclerosis susceptibility of ApoE−/−Dgat1−/− mice, we isolated
macrophages from chow-diet fed mice and analyzed them for lipid
uptake. The uptake of DiI-labeled acLDL was signiﬁcantly decreased
by 22%, whereas the uptake of DiI-VLDL was only slightly reduced
in ApoE−/−Dgat1−/− versus ApoE−/− cells (Fig. 4A, B). The mRNA ex-
pression of pro-atherosclerotic Sr-a was reduced by 76%, whereas
Cd36 levels were unaffected (Fig. 4C). Total DGAT activity was re-
duced by 64% in ApoE−/−Dgat1−/− compared with ApoE−/− macro-
phages (Fig. 4D). Nile red staining of untreated, acLDL- and VLDL-
loaded macrophages showed that the amount of lipid droplets was
markedly reduced in cells from ApoE−/−Dgat1−/− compared with
ApoE−/− mice (Fig. 4E). To analyze the in vivo foam cell formation,
we isolated macrophages of WTD-fed mice and determined the per-
centage of cells containing lipid droplets. Macrophages from ApoE−/−fter feeding Western type diet (WTD) for 9 weeks. TG, FFA, TC, and FC concentrations
ta are expressed as mean values±SEM. *pb0.05; ***p≤0.001.
TC (mg/dl) FC (mg/dl) CE (mg/dl)
09 322±14 105±2.2 217±13
37* 290±24 87.5±5.7* 203±19
93 905±27 471±18 434±15
55*** 735±35*** 337±18*** 398±19
Fig. 1. Reduced plaque formation in ApoE−/−Dgat1−/−mice. Female ApoE−/− and ApoE−/−Dgat1−/−mice were fed WTD for 9 weeks. Representative images and quantiﬁcations of
(A) oil red O-stained en face aorta and of aortic valve sections stained with (B) oil red O and (C) macrophage-speciﬁc anti-Moma2 antibody. (A) Data represent means (n=9–11) of
the quantiﬁcation of plaque formation. (B) Data represent the mean values of 10 aortic valve sections per mouse. Bars represent the mean values of 9–11 animals per group. C, Mean
values of 5 sections from 6 to 7 mice±SEM are shown. *pb0.05.
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with cells from ApoE−/− mice (Fig. 4F). These data indicate that
DGAT1 is required for efﬁcient foam cell formation of ApoE−/−macro-
phages and that its absence reduces lipid droplet accumulation.
4.6. Reduced cholesterol uptake and absorption in ApoE−/−Dgat1−/−
mice
We observed a reduced number of lipid droplets in livers of WTD-
fed ApoE−/−Dgat1−/− compared with ApoE−/−mice (Fig. 5A). In con-
trast, intestines of ApoE−/−Dgat1−/− mice exhibited a markedly in-
creased amount of lipid droplets when compared to ApoE−/− mice
(Fig. 5B) with elevated intestinal TC and TG concentrations (Fig. 5C).
These data indicate that TG and cholesterol accumulate within enter-
ocytes of ApoE−/−Dgat1−/−mice. In line with these data, we observed
reduced plasma cholesterol concentrations in ApoE−/−Dgat1−/− com-
pared with ApoE−/−mice (Table 1), whereas plasma bile acid concen-
trations were unchanged (supplemental Fig. S5).
DGAT1 inhibitor treatment reduced plasma cholesterol levels in
genetically obese KKAy mice [18]. The authors suggested that this
was mainly due to a decrease in intestinal cholesterol absorption
and/or reduction of hepatic cholesterol synthesis. We therefore deter-
mined intestinal cholesterol uptake and absorption in chow-fed
ApoE−/−Dgat1−/− and ApoE−/− mice after an intragastric bolus of
3H-cholesterol. In ApoE−/−Dgat1−/− mice, we found a strongly re-
duced amount of radioactivity in liver and plasma compared withApoE−/− mice (88% and 94%, respectively) with reductions in both
non-HDL- (94%) and HDL-cholesterol (91%) concentrations (Fig. 6A,
B). The decreased 3H-cholesterol level in the plasma was mainly
due to a decreased amount in the VLDL/chylomicron fraction
(Fig. 6C). 3H-cholesterol in the small intestine of ApoE−/−Dgat1−/−
mice was 82% reduced (Fig. 6D). Together with increased intestinal
TC levels these results demonstrate that ApoE−/−Dgat1−/− mice
have impaired cholesterol absorption efﬁciency through the intestine
and into plasma and liver. To assess the role of DGAT1 within entero-
cytes in the uptake of luminal cholesterol, we determined fractional
cholesterol absorption using the fecal dual-isotope method. As
shown in Fig. 6E, fractional absorption was 32% decreased in
ApoE−/−Dgat1−/− mice, indicating that enterocyte DGAT1 affects lu-
minal cholesterol absorption. Intestinal mRNA expression of Abca1,
Abcg1, Abcg5, Abcg8, Npc1l1 and Sr-b1 showed no signiﬁcant differ-
ences between both genotypes fed chow diet (supplemental Fig.
S6A). In intestines isolated from WTD-fed ApoE−/−Dgat1−/− mice
mRNA levels of Abca1 and Npc1l1 were slightly increased, whereas
Abcg1 and Sr-b1 were decreased (35% and by 22%, respectively)
(supplemental Fig. S6B).
Finally, we examined hepatic and intestinal cholesterol synthesis
by measuring the incorporation of 14C-acetate into cholesterol. He-
patic cholesterol synthesis was equivalent in ApoE−/−Dgat1−/− and
ApoE−/− mice (Fig. 6F), whereas intestinal cholesterol synthesis was
1.5-fold increased in ApoE−/−Dgat1−/− compared with ApoE−/−
mice (Fig. 6G).
Fig. 2. Reducedmonocyte recruitment in ApoE−/−Dgat1−/−mice. Total RNA was isolat-
ed from (A) aortas and (B) peritoneal macrophages of chow diet-fed animals. mRNA
levels of target genes were determined by real time PCR including normalization to
cyclophilin A. Expression of target genes in ApoE−/− aorta and macrophages was arbi-
trarily set to 1. Data represent mean values (n=6)±SEM. (C) Peritoneal macrophages
(MPM) and bone marrow-derived monocytes were added to the upper chamber of
transwell plates and allowed to migrate through the membrane into the lower cham-
ber containing DMEM and monocyte chemotactic protein-1 (MCP-1; 50 ng/ml). Cells
were incubated for 4 h at 37 °C. Migrated cells were counted by ﬂow cytometry. The
chemotactic index was calculated from the ratio of the cells that had moved in the
presence and absence of MCP-1. Data show the mean values (n=5) of two indepen-
dent experiments±SEM. (D) MCP-1 concentrations in the serum were determined
by ELISA. Data represent mean values (n=6–9)±SEM. *pb0.05; **p≤0.01;
***p≤0.001.
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Atherosclerotic arteries exhibit cellular and biochemical features
of inﬂammation [19] implying that atherosclerosis is a chronic in-
ﬂammatory disease [20]. Dgat1−/−mice exhibit reduced inﬂammato-
ry markers in adipose tissue [7]. It has been speculated that whole-
body DGAT1 deﬁciency is associated with reduced inﬂammation
due to the absence of DGAT1 in white adipose tissue, whereas
DGAT1 deﬁciency in macrophages increases the disposition to FA-
induced inﬂammation [7]. We therefore assessed the atherosclerosis
susceptibility of an atherosclerotic mouse model lacking DGAT1 in
the whole body. For our studies we used female ApoE−/− and
ApoE−/−Dgat1−/− mice. It is well established that there is a sex-
speciﬁc difference in atherosclerotic plaque formation between male
and female ApoE−/− mice with females being more prone to lesion
formation [21]. The plasma lipid proﬁle was markedly attenuated in
ApoE−/−Dgat1−/− compared with ApoE−/−mice with highly reduced
TG and substantially reduced TC and FC concentrations, highlighting
the importance of DGAT1 in the metabolic context of atherosclerosis.
ApoE−/−Dgat1−/− mice had reduced plaque development in the
aorta and in aortic valve sections after WTD feeding. The number of
macrophages within ApoE−/−Dgat1−/− lesions was reduced, indicating
a decreased inﬁltration of monocytes. Inﬁltrating macrophages take up
excessive lipids, become foam cells and are mainly responsible for thenecrotic core formations resulting in plaque destabilization. Themacro-
phage represents the link between intracellular cholesterol accumula-
tion and activation of the inﬂammatory pathway as these cells have
both scavenging and immunologic functions [19]. Cell leukocyte and
endothelial adhesion molecules (along with chemoattractant and acti-
vator molecules) mediate the migration of leukocytes during an in-
ﬂammatory response, thereby determining the susceptibility to
atherosclerotic fatty streak formations [22–24]. The reduced expression
of adhesion molecules in the aorta and decreased plasma MCP-1 con-
centration in ApoE−/−Dgat1−/− mice correlates with the observed re-
duced atherosclerosis susceptibility. The Vcam-1/Vla-4 pathway,
which mediates rolling and ﬁrm adhesion in leukocyte transendothe-
lial migration [25,26], was decreased in ApoE−/−Dgat1−/− mice. In ac-
cordance, migration efﬁciencies of ApoE−/−Dgat1−/− monocytes to
MCP-1 were reduced.
To investigate the role of macrophages with regard to reduced
atherosclerosis susceptibility of ApoE−/−Dgat1−/− mice in more de-
tail, we determined macrophage cholesterol efﬂux as the initial step
in the reverse cholesterol transport. Increased expression of ABCA1,
ABCG1 and SR-B1 as well as increased cholesterol efﬂux from
ApoE−/−Dgat1−/− compared with ApoE−/− and Dgat1−/− compared
with Wt macrophages indicated that (independent of the back-
ground) DGAT1 deﬁciency positively inﬂuences cholesterol efﬂux,
which is generally associated with an anti-atherosclerotic phenotype.
Both increased cholesterol efﬂux and decreased lipoprotein uptake
are important features in reducing macrophage lipid accumulation.
In accordance, macrophages from ApoE−/−Dgat1−/−mice were resis-
tant to lipid droplet accumulation by acLDL and VLDL loading, which
was consistent with reduced lipoprotein lipase (data not shown) and
DGAT activities. Sr-a mRNA expression was downregulated in acLDL-
loaded macrophages and might be the cause for the reduced uptake
of modiﬁed LDL in the absence of DGAT1 and a decreased foamy phe-
notype of macrophages isolated from WTD-fed ApoE−/−Dgat1−/−
mice.
ApoE−/−Dgat1−/−mice showed reduced lipid accumulation in the
liver but markedly increased TG and cholesterol content in the small
intestine. These ﬁndings indicate that DGAT1 deﬁciency in entero-
cytes has an impact on intestinal cholesterol absorption and therefore
might lead to lower plasma cholesterol levels. A complex interplay
between the liver and the intestine determines plasma cholesterol
concentrations. The liver regulates synthesis, secretion and clearance
of cholesterol-rich lipoproteins and determines the amount of choles-
terol eliminated into the bile, either as cholesterol or after conversion
to bile acids. The intestine plays a key role in regulating the net bal-
ance of cholesterol by serving as the site of both absorption of dietary
cholesterol and reabsorption of biliary cholesterol. Thus, cholesterol is
either absorbed by the intestine or excreted into the feces. DGAT1 de-
ﬁciency affected intestinal TG metabolism in ApoE−/−mice when the
dietary load of fat was high, comparable with Dgat1−/− mice [6].
Dgat1−/− mice have reduced postprandial triglyceridemic response
with less chylomicron release from the intestine compared with Wt
mice. In accordance, ApoE−/−Dgat1−/− mice accumulated lipid drop-
lets in the jejunum when fed a WTD rich in saturated FAs, suggesting
that DGAT2 and diacylglycerol transacylase contribute to intestinal
TG synthesis in the absence of DGAT1 [6]. DGAT1 deﬁciency, however,
reduced WTD-induced hepatic steatosis in ApoE−/− mice. A similar
reduction in liver steatosis, which involves the uptake of dietary FAs
and the activation of FA synthesis, was observed in Dgat1−/− mice
after a 3-week challenge with high fat diet [27]. The authors reported
a decrease of hepatic TG concentrations by 80% compared with Wt
mice. In the same publication hepatic deletion of DGAT1 was shown
to reduce TG concentrations in the liver by 50% [27], whereas
intestine-speciﬁc expression of DGAT1 reversed resistance to diet-
induced hepatic steatosis in Dgat1−/− mice [8]. Thus, increased TG
and TC concentrations and lipid droplet accumulation in the intes-
tines of ApoE−/−Dgat1−/− mice indicate that intestinal DGAT1
Fig. 3. Increased cholesterol efﬂux from ApoE−/−Dgat1−/− macrophages. Macrophages from chow diet-fed ApoE−/− and ApoE−/−Dgat1−/− mice were labeled with 3H-cholesterol
and cholesterol efﬂux to (A,B) ApoA1 and (C,D) HDL3 was assessed in the (A,C) absence and (B,D) presence of 8-bromo-cAMP. Cholesterol efﬂux was expressed as the percentage of
3H-cholesterol transferred from cells to the medium. Data show the mean values (n=4–6)±SEM of triplicate repeats. (E) Total RNA was isolated from acLDL-loaded macrophages.
mRNA expression of target genes was determined by real time PCR including normalization to cyclophilin A. Expression of target genes in ApoE−/− foam cells was arbitrarily set to 1.
Data represent mean values (n=6)±SEM. (F) Cell extracts of foam cells (40 μg per lane) were separated by SDS-PAGE. Protein expression of ABCA1, SR-B1 and ABCG1 were an-
alyzed by Western blotting relative to the expression of β-actin. *pb0.05; ***p≤0.001.
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ling TG and TC release.
We foundmarkedly decreased acute cholesterol uptake in the small
intestine of ApoE−/−Dgat1−/− mice and almost absent radioactivity
in plasma and liver 4 h after an intragastric bolus of 3H-cholesterol.
Absence of DGAT1 also resulted in reduced fractional cholesterol ab-
sorption as determined by the fecal dual-isotopemethod. These results
indicate that intestinal DGAT1 markedly affects dietary cholesterol up-
take. In intestines isolated from WTD-fed ApoE−/−Dgat1−/− mice
mRNA levels of Abca1 and Npc1l1 were slightly increased, whereas
Abcg1 and Sr-b1 were slightly decreased. All differences, however,
were less than 1.5-fold up- or downregulated, indicating that changes
in mRNA levels might not explain the phenotype of ApoE−/−Dgat1−/−
intestines.Our ﬁndings are in accordance with reduced cholesterol absorption
observed in genetically obese high fat diet-fed KKAy mice treated with
a DGAT1-speciﬁc inhibitor [18]. We suggest that in the absence of
DGAT1, less cholesterol accumulates in the plasma. A similar correla-
tion between a reduced ability of mice to absorb intestinal cholesterol
and decreased atherosclerotic lesion formation has been demonstrated
in ApoE−/− mice lacking the cholesterol transporter Niemann–Pick C1
Like 1 [16]. Our data indicate that less cholesterol uptake increases in-
testinal cholesterol biosynthesis, which was also demonstrated in
Niemann–Pick C1 Like 1-deﬁcient mice [16]. We hypothesize that
due to reduced secretion of chylomicrons from ApoE−/−Dgat1−/−
enterocytes, cholesterol resides within the small intestine, resulting
in decreased plasma TG and cholesterol concentrations, which contrib-
utes to the attenuation of plaque formation in these mice.
Fig. 4. Reduced foam cell formation of ApoE−/−Dgat1−/− macrophages. (A,B) Macrophages from chow diet-fed ApoE−/− and ApoE−/−Dgat1−/− mice were cultured for 24 h in
DMEM/10% LPDS. Cells were then incubated for 4 h in serum-free DMEM with (A) 10 μg/ml 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI)-acLDL or
(B) 50 μg/ml DiI-VLDL. Cells were washed, detached, stained with F4/80 antibody and analyzed by ﬂuorescence activated cell sorting. Data show the mean values (n=3)±SEM.
(C) Total RNA was isolated from acLDL-loaded macrophages. mRNA levels of Sr-a and Cd36 were determined by real time PCR including normalization to cyclophilin A. Expression
of target genes in ApoE−/− foam cells was arbitrarily set to 1. Data represent mean values (n=6)±SEM. (D) DGAT activity was determined in 50 μg macrophage lysates using
200 μM sn-1,2-dioleoylglycerol and 25 μM 14 C-oleoyl-CoA (ARC Inc., St. Louis, MO) as substrates and 10 mM MgCl2. Data show the mean values (n=4)±SEM. (E) Representative
images of Nile red-stained control, acLDL-and VLDL-loaded macrophages. Lipid droplets were visualized by confocal laser scanning microscopy. Original magniﬁcation, ×63.
(F) ApoE−/− and ApoE−/−Dgat1−/−mice were fed a WTD for 9 weeks. Macrophages were isolated, cultured for 2 h in serum-free DMEM and stained with Nile Red. Data represent
the percent±SEM of lipid droplet-containing cells from at least 500 cells per genotype. *pb0.05; **p≤0.01; ***p≤0.001.
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DGAT1 inhibitors were shown to induce weight loss and improve
insulin sensitivity, glucose tolerance and lipid levels in obese ani-
mals [28,29], suggesting that DGAT1 inhibitors may be beneﬁcial
drugs to treat obesity, diabetes and dyslipidemia. Here wedemonstrate that the lack of DGAT1 decreases atherosclerotic pla-
que formation. Contributing factors include reduced macrophage
migration and aortic inﬂammation, increased cholesterol efﬂux
from macrophages, and decreased cholesterol uptake and absorp-
tion. We conclude that different mechanisms are operative in mac-
rophages and intestine. In macrophages lacking DGAT1, the
Fig. 5. Number of lipid droplets are reduced in liver but increased in intestine of ApoE−/−Dgat1−/−mice. ApoE−/− and ApoE−/−Dgat1−/−mice were fed aWTD for 9 weeks. Representative
images of oil redO-stained sections of (A) liver and (B) intestine. Lipid dropletswere visualized using aNikon Eclipse 80imicroscope. A,B, upper lane: originalmagniﬁcation, ×4; B, lower lane:
original magniﬁcation, ×10. Scale bars: 500 μm. (C) Intestinal TG (n=3) and TC (n=4) concentrations were determined enzymatically. Values are means±SEM. **pb0.01.
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cholesterol result in markedly reduced foam cell formation. In addi-
tion to the reduced mobility of these macrophages this leads to less
inﬂammation in the aorta and reduced atherosclerotic plaque for-
mation. The uptake and absorption of cholesterol are markedly re-
duced in ApoE−/−Dgat1−/− mice, leading to increased cholesterol
biosynthesis. The decrease in plasma lipid parameters (including
cholesterol) and elevated intestinal cholesterol concentrations are
likely a result of less secretion of chylomicrons from ApoE−/−
Dgat1−/− intestines. Although the respective roles of DGAT1 in
macrophage function versus intestinal lipid absorption with respect
to atherosclerotic plaque formation are still unknown, our study
provides strong evidence that whole-body DGAT1 deﬁciency isatheroprotective, implicating an additional application of DGAT1
inhibitors.
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